Immunomodulatory and cytotoxic activities of euphol

This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines. CP and AP we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 2021-09, Vol.280, p.119700-119700, Article 119700
Hauptverfasser: de Oliveira, Thais Latansio, Bavia, Lorena, Fontana, Pâmela Dias, Cruz, Luiza Stolz, Paludo, Katia Sabrina, Crisma, Amanda Rabello, Messias-Reason, Iara Jose, Beltrame, Flávio Luís
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 119700
container_issue
container_start_page 119700
container_title Life sciences (1973)
container_volume 280
creator de Oliveira, Thais Latansio
Bavia, Lorena
Fontana, Pâmela Dias
Cruz, Luiza Stolz
Paludo, Katia Sabrina
Crisma, Amanda Rabello
Messias-Reason, Iara Jose
Beltrame, Flávio Luís
description This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines. CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining. Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines. Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment. [Display omitted] •Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases.
doi_str_mv 10.1016/j.lfs.2021.119700
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2540520219</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S002432052100686X</els_id><sourcerecordid>2540520219</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</originalsourceid><addsrcrecordid>eNp9kE1LxDAURYMoOI7-AHcFN25aX9KmaXEl4sfAgBtdh_QlxZS2GZN0cP69HerKhau3Offy7iHkmkJGgZZ3Xda3IWPAaEZpLQBOyIpWok6hzOkpWQGwIs0Z8HNyEUIHAJyLfEXyzTBMoxucnnoVnT8katQJHqKL7ttiojDavY3WhMS1iZl2n66_JGet6oO5-r1r8vH89P74mm7fXjaPD9sUc17FlBac0oYxqivBFebQVICG1dCUtWgqo0vEFhVWrWg16qaoSyYqpmvkZa1Kka_J7dK78-5rMiHKwQY0fa9G46YgGS-AHyfXM3rzB-3c5Mf5u5nivKwEnUWsCV0o9C4Eb1q583ZQ_iApyKNG2clZozx2ykXjnLlfMmZeurfGy4DWjGi09Qaj1M7-k_4ByO55sg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555687106</pqid></control><display><type>article</type><title>Immunomodulatory and cytotoxic activities of euphol</title><source>Elsevier ScienceDirect Journals Complete</source><creator>de Oliveira, Thais Latansio ; Bavia, Lorena ; Fontana, Pâmela Dias ; Cruz, Luiza Stolz ; Paludo, Katia Sabrina ; Crisma, Amanda Rabello ; Messias-Reason, Iara Jose ; Beltrame, Flávio Luís</creator><creatorcontrib>de Oliveira, Thais Latansio ; Bavia, Lorena ; Fontana, Pâmela Dias ; Cruz, Luiza Stolz ; Paludo, Katia Sabrina ; Crisma, Amanda Rabello ; Messias-Reason, Iara Jose ; Beltrame, Flávio Luís</creatorcontrib><description>This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines. CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining. Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines. Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment. [Display omitted] •Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2021.119700</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Addictions ; Apoptosis ; Cell death ; Cell morphology ; Chemotaxis ; Chromatin ; Complement ; Complement activation ; Complement system ; Cytology ; Cytotoxicity ; Enzyme-linked immunosorbent assay ; Euphorbia umbellata ; Evaluation ; Immunomodulation ; Inflammation ; Inflammatory diseases ; Latex ; Leukocyte migration ; Leukocytes (neutrophilic) ; Monoclonal antibodies ; Morphology ; Mortality ; Neutrophils ; Rounding ; Toxicity</subject><ispartof>Life sciences (1973), 2021-09, Vol.280, p.119700-119700, Article 119700</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright Elsevier BV Sep 1, 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</citedby><cites>FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lfs.2021.119700$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>de Oliveira, Thais Latansio</creatorcontrib><creatorcontrib>Bavia, Lorena</creatorcontrib><creatorcontrib>Fontana, Pâmela Dias</creatorcontrib><creatorcontrib>Cruz, Luiza Stolz</creatorcontrib><creatorcontrib>Paludo, Katia Sabrina</creatorcontrib><creatorcontrib>Crisma, Amanda Rabello</creatorcontrib><creatorcontrib>Messias-Reason, Iara Jose</creatorcontrib><creatorcontrib>Beltrame, Flávio Luís</creatorcontrib><title>Immunomodulatory and cytotoxic activities of euphol</title><title>Life sciences (1973)</title><description>This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines. CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining. Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines. Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment. [Display omitted] •Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases.</description><subject>Addictions</subject><subject>Apoptosis</subject><subject>Cell death</subject><subject>Cell morphology</subject><subject>Chemotaxis</subject><subject>Chromatin</subject><subject>Complement</subject><subject>Complement activation</subject><subject>Complement system</subject><subject>Cytology</subject><subject>Cytotoxicity</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Euphorbia umbellata</subject><subject>Evaluation</subject><subject>Immunomodulation</subject><subject>Inflammation</subject><subject>Inflammatory diseases</subject><subject>Latex</subject><subject>Leukocyte migration</subject><subject>Leukocytes (neutrophilic)</subject><subject>Monoclonal antibodies</subject><subject>Morphology</subject><subject>Mortality</subject><subject>Neutrophils</subject><subject>Rounding</subject><subject>Toxicity</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAURYMoOI7-AHcFN25aX9KmaXEl4sfAgBtdh_QlxZS2GZN0cP69HerKhau3Offy7iHkmkJGgZZ3Xda3IWPAaEZpLQBOyIpWok6hzOkpWQGwIs0Z8HNyEUIHAJyLfEXyzTBMoxucnnoVnT8katQJHqKL7ttiojDavY3WhMS1iZl2n66_JGet6oO5-r1r8vH89P74mm7fXjaPD9sUc17FlBac0oYxqivBFebQVICG1dCUtWgqo0vEFhVWrWg16qaoSyYqpmvkZa1Kka_J7dK78-5rMiHKwQY0fa9G46YgGS-AHyfXM3rzB-3c5Mf5u5nivKwEnUWsCV0o9C4Eb1q583ZQ_iApyKNG2clZozx2ykXjnLlfMmZeurfGy4DWjGi09Qaj1M7-k_4ByO55sg</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>de Oliveira, Thais Latansio</creator><creator>Bavia, Lorena</creator><creator>Fontana, Pâmela Dias</creator><creator>Cruz, Luiza Stolz</creator><creator>Paludo, Katia Sabrina</creator><creator>Crisma, Amanda Rabello</creator><creator>Messias-Reason, Iara Jose</creator><creator>Beltrame, Flávio Luís</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20210901</creationdate><title>Immunomodulatory and cytotoxic activities of euphol</title><author>de Oliveira, Thais Latansio ; Bavia, Lorena ; Fontana, Pâmela Dias ; Cruz, Luiza Stolz ; Paludo, Katia Sabrina ; Crisma, Amanda Rabello ; Messias-Reason, Iara Jose ; Beltrame, Flávio Luís</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-14511b221d875ac30b80ce290b697b8ed6ccfcac8f7fdcdb4962782d9c569a673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Addictions</topic><topic>Apoptosis</topic><topic>Cell death</topic><topic>Cell morphology</topic><topic>Chemotaxis</topic><topic>Chromatin</topic><topic>Complement</topic><topic>Complement activation</topic><topic>Complement system</topic><topic>Cytology</topic><topic>Cytotoxicity</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Euphorbia umbellata</topic><topic>Evaluation</topic><topic>Immunomodulation</topic><topic>Inflammation</topic><topic>Inflammatory diseases</topic><topic>Latex</topic><topic>Leukocyte migration</topic><topic>Leukocytes (neutrophilic)</topic><topic>Monoclonal antibodies</topic><topic>Morphology</topic><topic>Mortality</topic><topic>Neutrophils</topic><topic>Rounding</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Oliveira, Thais Latansio</creatorcontrib><creatorcontrib>Bavia, Lorena</creatorcontrib><creatorcontrib>Fontana, Pâmela Dias</creatorcontrib><creatorcontrib>Cruz, Luiza Stolz</creatorcontrib><creatorcontrib>Paludo, Katia Sabrina</creatorcontrib><creatorcontrib>Crisma, Amanda Rabello</creatorcontrib><creatorcontrib>Messias-Reason, Iara Jose</creatorcontrib><creatorcontrib>Beltrame, Flávio Luís</creatorcontrib><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Oliveira, Thais Latansio</au><au>Bavia, Lorena</au><au>Fontana, Pâmela Dias</au><au>Cruz, Luiza Stolz</au><au>Paludo, Katia Sabrina</au><au>Crisma, Amanda Rabello</au><au>Messias-Reason, Iara Jose</au><au>Beltrame, Flávio Luís</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunomodulatory and cytotoxic activities of euphol</atitle><jtitle>Life sciences (1973)</jtitle><date>2021-09-01</date><risdate>2021</risdate><volume>280</volume><spage>119700</spage><epage>119700</epage><pages>119700-119700</pages><artnum>119700</artnum><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>This study evaluated the effect of euphol isolated from Euphorbia umbellata (Pax) Bruyns latex on the activation of complement pathways (classical (CP), alternative (AP) and lectin (LP)), neutrophil chemotaxis, cytotoxic activity, cell morphology and death in HRT-18 and 3T3 cells lines. CP and AP were assessed using hemolytic assays and ELISA for LP; neutrophil chemotaxis was performed using Boyden's chamber; cytotoxicity was evaluated by neutral red methodology and characteristics of cell death were assessed by cell morphology with hematological staining. Although euphol increased CP activation (38% at a concentration of 976.1 μM), an inhibitory effect on AP, LP (31% and 32% reduction in the concentration of 976.1 μM) and neutrophil chemotaxis (inhibit 84% of neutrophil migration at a concentration 292.9 μM) was observed. In addiction euphol was able to induce significant cell death in a time-dependent manner, presenting an IC50 of 70.8 μM and 39.2 μM for HRT-18 and 3T3 cell lines respectively and it was also observed apoptotic characteristics as cellular rounding, chromatin condensation and blebs formation for both cell lines. Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. On the other hand, the controlled activation of CP can contribute to complement-dependent cytotoxicity in the context of monoclonal antibody-based cancer treatment. [Display omitted] •Euphol modulates the activation of complement, neutrophils migration and induces cell cytotoxicity.•Euphol is a promising candidate for anticancer therapy.•Euphol has potential to be used in the treatment of complement-related inflammatory diseases.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.lfs.2021.119700</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 2021-09, Vol.280, p.119700-119700, Article 119700
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_2540520219
source Elsevier ScienceDirect Journals Complete
subjects Addictions
Apoptosis
Cell death
Cell morphology
Chemotaxis
Chromatin
Complement
Complement activation
Complement system
Cytology
Cytotoxicity
Enzyme-linked immunosorbent assay
Euphorbia umbellata
Evaluation
Immunomodulation
Inflammation
Inflammatory diseases
Latex
Leukocyte migration
Leukocytes (neutrophilic)
Monoclonal antibodies
Morphology
Mortality
Neutrophils
Rounding
Toxicity
title Immunomodulatory and cytotoxic activities of euphol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A00%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunomodulatory%20and%20cytotoxic%20activities%20of%20euphol&rft.jtitle=Life%20sciences%20(1973)&rft.au=de%20Oliveira,%20Thais%20Latansio&rft.date=2021-09-01&rft.volume=280&rft.spage=119700&rft.epage=119700&rft.pages=119700-119700&rft.artnum=119700&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2021.119700&rft_dat=%3Cproquest_cross%3E2540520219%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555687106&rft_id=info:pmid/&rft_els_id=S002432052100686X&rfr_iscdi=true